Remedium Lifecare’s shares have surged by 5% as the company’s board is set to discuss the possibility of issuing foreign currency bonds and acquiring new assets. This move has attracted investors, causing a rise in the stock price. The stock, priced at ₹10, has shown promising growth potential in the stock market. Investors are keeping a close eye on the developments as they await further announcements from the company.